Harry serves as an Innovate UK Council Member and founded Science Creates Ventures. He holds non-executive director roles across several life sciences and therapeutics companies.
Catherine serves as a general partner at SCVC and European Women in VC. She also holds non-executive director and board observer roles across several companies.
The pre-seed round was led by Science Creates Ventures with backing from a syndicate of institutional and angel investors.
"The UK would massively benefit from delivering major infrastructure projects on time and on budget, and through increased productivity by reducing the time it takes to bring such projects to the point of benefitting people. A big part of this is the difficulty found in mapping the complex unseen environments and hidden critical infrastructure that resides under the ground. Considerable budgets are allocated to ensure that unexpected obstacles can be overcome. On HS2 alone, the contingency for unforeseen ground conditions is £248m."
The funding round was led by Science Creates Ventures and Green Angel Syndicate to support manufacturing pilots.
"This landmark investment enables Kelpi to scale up our pioneering work using seaweed to create bioplastic packaging with the barrier properties required by clients"
Foresight Williams Technology led the oversubscribed round alongside several regional and specialist investors.
"We are excited to announce our support for such a forward thinking and innovative business. Nebu~Flow’s development of delivery mechanisms tailored to specific drugs represents an opportunity to expand the market and improve patient outcomes. Foresight Williams Technology’s expertise will offer significant value as the Company develops its products, and we look forward to working with the team at Nebu~Flow during the next stage of their growth."
